Fda Expands Approved Use of Stivarga (Regorafenib) to Treat
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib. This is the first FDA-approved treatment for a liver cancer in almost a decade......

https://www.drugs.com/newdrugs/fda-expands-approved-stivarga-regorafenib-hepatocellular-carcinoma-4522.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Expands+Approved+Use+of+Stivarga+(regorafenib)+to+Treat+Hepatocellular+Carcinoma
N●●●i R●●●t and 1 others like this
Like
Comment
Share